The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF

A. D'Addio, A. Curti, N. Worel, K. Douglas, M. R. Motta, S. Rizzi, E. Dan, S. Taioli, V. Giudice, H. Agis, G. Kopetzky, R. Soutar, B. Casadei, M. Baccarani, R. M. Lemoli

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF'. Together they form a unique fingerprint.

Medicine & Life Sciences